FDA approves sale of genetic tests for risk of Alzheimer’s and other diseases

(By Meghana Keshavan for STAT)

Consumers will soon be able to mail a saliva sample to genetic testing company and get back data on their risk for developing diseases such as Parkinson’s, late-onset Alzheimer’s, and celiac disease.  Continue reading article here…


Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.

Leave a Reply